CEACAM5 and cancer: Although widely used for the follow-up of digestive tract malignancies, CEA production varies according to cancer location, histologic subtypes in different disease stages and its concentration can be influenced by non-malignant conditions and inflammation-inducing external factors such as smoking [21].